Recent Headlines
Thermo Fisher Partners with ALPCO-GeneProof to Broaden Their CE-IVD Molecular Assay Portfolio
ALPCO-GeneProof, a global leader in diagnostics, and Thermo Fisher announced a strategic partnership that brings the TaqPath Menu | GeneProof PCR kits to market. The partnership combines the strengths of ALPCO-GeneProof’s expertise in molecular diagnostics with Thermo Fisher’s robust... - April 17, 2023 - ALPCO
New Pivotal Data Demonstrates Clinical Feasibility of GeneFluidics’ Direct-from-Specimen AST in Clinical Settings
GeneFluidics, Inc. is pleased to announce a joint publication with the Medical College of Wisconsin (MCW) that introduces rapid antimicrobial susceptibility testing (AST), which would represent a paradigm shift in the clinical management of microbial infections. The data from the MCW study have... - November 04, 2022 - GeneFluidics Inc.
Minus K Technology Announces Announces Its Seventh U.S. Educational Giveaway of Vibration Isolators to Colleges and Universities
As Minus K celebrates their upcoming 30 years in business, they are giving away $25,000* dollars worth of passive mechanical patented superior performing negative-stiffness low-frequency vibration isolators to colleges in the United States. - October 25, 2022 - Minus K Technology Inc.
American Laboratory Products Company Merges with GeneProof
American Laboratory Products Company, Ltd. (“ALPCO”), a specialty in vitro diagnostics company, today announced a merger with GeneProof a.s. (“GeneProof”), a leading molecular diagnostics company based in Brno, Czech Republic. The combination creates a global market leader... - April 21, 2022 - ALPCO
ALPCO Announced Its Support of the Ukrainian People in a Company-Wide Communication to Its Employees
ALPCO (Salem, NH) announced its support of the Ukrainian people in a company-wide communication to its employees. The message outlined the company's contribution to aid refugees through the American Red Cross and Project Hope in the amount of $5,000 each. Additionally, ALPCO is offering an... - March 16, 2022 - ALPCO
MacroArray Diagnostics GmbH (MADx) Partners with ALPCO to Offer a Fully Automated Sample-to-Answer Multiplex Allergy Test Solution to the North American Market
ALPCO (Salem, NH), a leading US producer of novel immunoassay testing platforms, recently announced an exclusive distribution partnership with MacroArray Diagnostics GmbH (Vienna, Austria). Together, they offer a comprehensive line of testing solutions for allergies (IgE-based) and food intolerances (IgG-based), from test material to proprietary hardware and software to process and analyze samples. - February 01, 2022 - ALPCO
OmeCare and Hillsborough City School District Renew Partnership for Student and Faculty COVID-19 PCR Testing
Partnership helps district ensure safety standards and meet COVID-19 testing protocols for the 2021-2022 school year. - October 16, 2021 - OmeCare
OmeCare and LifeSite Announce COVID-19 Testing Solution Partnership
The partnership provides a turnkey approach for workplaces, schools, major conventions and other group events looking to ensure safety and meet governmental mandates for students, staff, employees and event participants. - October 01, 2021 - OmeCare
AdvantaPure(R) Announces Fall Trade Show Appearances - Includes Events in the Northeast U.S.
AdvantaPure, the high purity division of NewAge Industries, will exhibit its silicone and TPE tubing and molded assemblies at the ISPE Boston Show, BioProcess International 2021, and Interphex, all taking place in September and October. AdvantaPure will also highlight its recent clean room expansion and its in-process building renovation at the events. The company is increasing its tubing manufacturing capacity to help meet demand for its Single-Use products. - September 16, 2021 - AdvantaPure
Scientists at AbboMax, Inc. Developed the New Panels of Monoclonal Antibodies to Study B- and T-Cell Lymphomas
Lymphoma is a malignant transformation of either B or T cells or their subtypes. All lymphoma subtypes combined are the seventh most common cancer in the United States. The B-cell lymphomas are types of lymphoma affecting B cells. About 85% of lymphomas are of B-cell origin. T-cell lymphomas are lymphomas that affect T cells. AbboMax has developed the new panels of monoclonal antibodies to study B- and T-cell lymphomas. - September 03, 2021 - AbboMax, Inc.
Foxx Life Sciences Celebrates Major Expansion
Foxx Life Sciences celebrates two new manufacturing facilities in Londonderry, New Hampshire and Hyderabad, India. The new locations add four additional SUT (Single Use Technologies) Cleanrooms that will allow Foxx to meet the high demands of their biotechnology and biopharmaceutical customers. New... - August 04, 2021 - Foxx Life Sciences
Advanced Silicon Group Closes Seed Preferred Equity Offering and Adds Alan Watson and Sarah Kelly to Board
Advanced Silicon Group, Inc. (ASG), a pioneer in silicon nanotechnology focused on developing novel biosensors, announced today the closing of a $1,020,000 seed preferred stock offering led by Cherrystone Angel Group with participation by MIT Alumni Angels of Northern California, Sidecar Angels and other private investors and the addition of two new Directors, Alan Watson, PhD, MBA and Sarah Kelly, PhD to its Board of Directors. - May 16, 2021 - Advanced Silicon Group
GeneThera, Inc. Wastewater Testing: a Way to Better Control the COVID-19 Pandemic
The global COVID-19 pandemic has demonstrated that neither current systems nor related technologies are capable of preventing or even successfully controlling the spread of zoonotic infectious agents. One of the prominent features of these infectious organisms is their ability to infect both people... - March 30, 2021 - GeneThera Inc.
AbboMax Introduces a Panel of Monoclonal and Polyclonal Anti-Connexin Antibodies
AbboMax introduces a panel of monoclonal and polyclonal anti-connexin antibodies. There are 21 different types of connexins which are known to exist in humans and 20 types in mice. Their abnormal expression and function are associated with human hereditary diseases. AbboMax has been developing & manufacturing high performance immunoassay reagents for many years in California. - March 15, 2021 - AbboMax, Inc.
AbboMax is Pleased to Introduce the Collection of Monoclonal and Polyclonal Anti-STAT Antibodies
STAT proteins (Signal transducers and activators of transcription) are cytoplasmic transcription factors that play an essential role in transmitting signals from the cellular membrane to the nucleus. Misregulation of STAT pathway frequently leads to tumorogenesis. AbboMax introduces a panel of monoclonal and polyclonal anti-STAT antibodies. - February 27, 2021 - AbboMax, Inc.
14 New Monoclonal Anti-Cytokeratin Antibodies from AbboMax
AbboMax adds over a dozen new anti-cytokeratin monoclonal antibodies to its inventory. Cytokeratins are proteins found in epithelium. A variety of cytokeratins can be used for subtyping various forms of epithelial differentiation or for the detection of possible sites of origin of tumors. Primary tumors usually recapitulate the cytokeratin profiles of the cells from which they are derived. They are one of the most effective epithelial differentiation and tumor markers. - January 13, 2021 - AbboMax, Inc.
Erica Cai Named ALPCO’s Summer 2020 Diabetes Research Travel Grant Recipient
Today ALPCO announced Erica Cai from Harvard Medical School as the latest recipient of its Diabetes Research Travel Grant. Dr. Cai is a postdoctoral fellow from the Joslin Diabetes Center researching the mechanism of autoimmunity that leads to beta cell destruction and type 1 diabetes (T1D). Dr. - November 10, 2020 - ALPCO
Tornado Spectral Systems Achieves ISO 9001:2015 Certification
Tornado Spectral Systems Inc., a leading manufacturer of Raman analyzers for process monitoring, is proud to announce that it has achieved ISO 9001:2015 certification. Acquiring ISO 9001:2015 reinforces Tornado’s commitment to exceeding quality expectations and requirements of its... - October 03, 2020 - Tornado Spectral Systems
Ampersand Capital Partners Acquires American Laboratory Products Company
American Laboratory Products Company, Ltd. (ALPCO), a specialty in vitro diagnostics company, today announced the majority recapitalization of the company by Ampersand Capital Partners. Ampersand’s investment will be used to support ALPCO’s worldwide growth initiatives, including the... - September 21, 2020 - ALPCO
Scientists at AbboMax, Inc. Created a TBNK Panel of Monoclonal Antibodies to Study SARS-CoV-2
Understanding of a host immune response to SARS-CoV-2 is extremely important. It was previously shown that the immune system of patients infected by SARS-CoV-2 is severely impaired. In order to better recognize how immune response is orchestrated, the TBNK (B-Cell, T-Cell, and natural killer cells) panel of antibodies created by AbboMax, Inc. can be employed. - July 22, 2020 - AbboMax, Inc.
AdvantaPure(R) Now Offers GORE(R) STA-PURE(R) Pump Tubing, an Industry Staple for Single-Use Biotech and Pharmaceutical Processes
AdvantaPure is now a systems integrator of GORE STA-PURE Pump Tubing, Series PCS. The AdvantaPure team is expert at molding connections for tubing assemblies and can overmold GORE STA-PURE Pump Tubing as the pump element in biopharm and pharmaceutical assemblies. The overmolding process results in a smooth contact surface for optimal fluid flow. GORE STA-PURE Pump Tubing connects to any of AdvantaPure’s AdvantaSil(R) platinum-cured silicone tubing using overmolding technology. - June 17, 2020 - AdvantaPure
Zeteo Biomedical Introduces ZEOx1 AquilaMD™ Ophthalmic Drug Delivery System
Zeteo’s patient-centric ophthalmic delivery systems are designed for precise, self-administration of preservative free drugs and biopharmaceuticals. - June 01, 2020 - Zeteo Biomedical LLC
Zeteo Biomedical Receives NIH Award to Develop a Universal Nasal Flu Vaccine in Collaboration with the Iowa State University Nanovaccine Institute
Vaccines that can be quickly manufactured, deployed and self-administered at global scale volumes is crucial to protect global populations against pandemic virus threats. - May 20, 2020 - Zeteo Biomedical LLC
Zeteo Biomedical Introduces ZEOx1 Orion(TM) Nasal Vaccine and Drug Delivery Systems
Zeteo’s patient-centric delivery systems are designed for quick manufacturing to facilitate rapid deployment of drugs and vaccines to global populations. - May 14, 2020 - Zeteo Biomedical LLC
Minus K Technology Releases Its New CT-2 Ultra-Thin, Low-Frequency Passive Vibration Isolator
Minus K's New Ultra-Thin CT-2 Negative-Stiffness Passive Vibration Isolation Platform at Just 2-1/2 Inches in height Isolates Vibrations as Low as 1 Hertz Without the Need for Air or Electricity. - May 07, 2020 - Minus K Technology Inc.
Virun and East West Bank Partner-Up to Save Lives
VIRUN Nutra-biosciences was able to get fully funded with the help of East West Bank. VIRUN manufactures food products and dietary supplements and are considered part of the essential workforce. Virun makes immune boosting products such as liposomal Vitamin C and patented, clinically proven Glutathione Tripeptides bound to Lactoferrin that have shown success in trials toward innate immunity. - April 22, 2020 - VIRUN
Marlena Holter Named ALPCO’s Winter 2020 Diabetes Research Travel Grant Recipient
ALPCO's Winter 2020 Diabetes Research Travel Grant has been awarded to Marlena Holter, a DVM/PhD candidate from Cornell University’s College of Veterinary Medicine. Ms. Holter’s novel research focuses on GLP-1 regulated glucose regulation following vertical sleeve gastrectomy surgery to define the mechanisms underlying type 2 diabetes remission and metabolic improvement following bariatric surgery. - April 14, 2020 - ALPCO
ATEX Certified Raman Analyzer Now Available from Tornado Spectral Systems
OPIS 35 Provides “Inherently Safe” Laser Radiation for Zone 0 Hazardous Location - March 13, 2020 - Tornado Spectral Systems
New NF-kB Panel of Antibodies from AbboMax and Human Diseases
NF-kB is a protein complex that controls the transcription of DNA. It is a heterodimer sequestered in the cytoplasm. In response to activation NF-kB translocates to the nucleus to 'turn on' the expression of specific genes that keeps a cell proliferating and protects it from apoptosis. AbboMax has developed a panel of NF-kB related antibodies. - December 22, 2019 - AbboMax, Inc.
Virun® Making an Impact at PGA Show January 2020
Virun® will be amongst the 1,000+ interactive exhibitors attending the PGA Merchandise Show in Orlando, Florida January 21 through January 24. - December 06, 2019 - VIRUN
ALPCO Announces Deadline for Winter 2020 Diabetes Research Travel Grant Award
ALPCO announced the submission deadline for its Winter 2020 Diabetes Research Travel Grant Award. Each recipient is awarded up to $2500 to present their research at a relevant conference and a $2500 product credit. - December 04, 2019 - ALPCO
Good News: a Panel of TGF-Beta and TGF-Beta Receptor Antibodies is Created by Abbomax
TGF-β regulates multiple biological processes, including embryonic development, adult stem cell differentiation, proliferation, homeostasis, immune regulation, wound healing, and inflammation. Multiple cells synthesize TGF-β and many cells have specific receptors for this peptide. AbboMax created a panel of TGF-β and TGF-β receptors antibodies. AbboMax, Inc. has been developing & manufacturing antibodies, FFPE cell pellets slides, for many years in California. - November 23, 2019 - AbboMax, Inc.
Nuriv® Delivers Impressive Lineup of Patented CBD Formulations
Nuriv® releases patented CBD formulations: RELAX, SLEEP, JOINT, along with its stand-alone CBD products, Hazelnut, Chocolate Brownie and French Vanilla. These release a powerfull Micellized form of CBD in amazing flavors, such as Peanut Butter Cup and Chocolate Brownie. Micellized compounds that are water insoluble absorb quicker, half speedy onset and improved Pharmacokinetics. 20mg CBD per 10ml serving and 22 servings per 8oz. - November 20, 2019 - VIRUN
ALPCO Launches Analytically Specific Human and Rodent STELLUX® Glucagon ELISA
ALPCO's new STELLUX® Chemiluminescence Glucagon ELISA features increased analytical specificity and a broad range to accurately quantify glucagon levels between 0.86 and 143.7 pmol/L (3-500 pg/mL) in human and rodent samples. - November 06, 2019 - ALPCO
ALPCO’s New Fecal Calprotectin ELISA with Superior Clinical Accuracy Receives FDA 510(k) Clearance
ALPCO received 510(k) clearance from the US FDA for its new fecal Calprotectin Chemiluminescence ELISA test. The ALPCO Calprotectin Chemiluminescence ELISA’s superior clinical accuracy will enable clinical laboratories to provide the most accurate results to gastroenterologists facing the challenges of differentiating IBD from IBS. - October 30, 2019 - ALPCO
Scintica Instrumentation and Aspect Imaging Announce Exclusive Agreement for Pre-Clinical MRI Imaging Products
Scintica Instrumentation Inc. is excited to announce its exclusive distribution agreement with Aspect Imaging for the M-Series(TM) MRI systems for scientific research. With more than 100 MRI installations worldwide, Aspect’s compact MRI systems are self-shielding, cryogen free and do not need... - September 18, 2019 - Scintica Instrumentation
BPOG Extractables Testing of AdvantaPure(R)’s Key Silicone and TPE Tubing Products is Complete; Test Results Help Drug Manufacturers Compare Tubing
BioPhorum Operations Group extractables testing was recently completed on several of AdvantaPure’s tubing and hose products. The fluid transfer products are typically used in biopharm and pharmaceutical manufacturing processes. The Group’s standardized extractables test protocol was followed and performed by an independent lab and involved testing to four different exposure times as long as 70 days. The comprehensive testing was undertaken by AdvantaPure to meet customer requests. - May 31, 2019 - AdvantaPure
Scientists at AbboMax Developed Antibodies Against PINK1 and Parkin to Study Parkinson’s Disease
A panel of PINK1 and Parkin antibodies was developed at Abbomax to investigate Parkinson’s disease (PD). These phosphospecific and paired antibodies would be useful tools for studies of PINK/Parkin pathways and signaling in PD. AbboMax has been developing & manufacturing high performance immunoassay reagents for many years in California. AbboMax specializes in high-quality custom service and products focusing on antibody and assay development. - May 09, 2019 - AbboMax, Inc.
NanoCellect Biomedical Begins Distribution to Europe
NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced an exclusive distribution agreement with Basel, Switzerland-based Bucher Biotec AG. The agreement covers sales in Switzerland of NanoCellect’s... - May 01, 2019 - NanoCellect
New Low-Height, Low-Frequency Vibration Isolation Platform Adapts to Space Constraints in Critical Micro- and Nano-Microscopy
At just 2-1/4 inches in height, while isolating vibrations as low as 1 hertz, the new completely-passive Negative-Stiffness tabletop vibration isolation platform – developed by Minus K Technology – provides the industry’s thinnest low-height, low-frequency isolator for optimizing space in critical microscopy and laboratory applications. - March 14, 2019 - Minus K Technology Inc.
Scintica Instrumentation to Distribute the VelO2x Hypoxia Chamber System from Baker Ruskinn
Scintica Instrumentation Inc. is excited to announce its recent distribution agreement for the Baker Ruskinn preclinical VelO2x hypoxia chamber for scientific research. The VelO2x system has been engineered to provide an isolated and highly controlled oxygen environment to help researchers better understand how O2 levels affect various conditions such as sleep apnea, systemic hypertension, pulmonary dysfunction, ischemia and much more. - March 07, 2019 - Scintica Instrumentation
ALPCO Announces January 2019 Young Investigator Award Recipient of Its Diabetes Research Travel Grant
ALPCO awards its January 2019 Diabetes Research Travel Grant to Lisa Volpatti at Massachusetts Institute of Technology. - February 05, 2019 - ALPCO
Euphrates Vascular Announces FDA Clearance of the ICHOR Reperfusion System
Euphrates Vascular, a company focused on the treatment of vascular occlusions, recently received 510(k) clearance for sale of its ICHOR Percutaneous Reperfusion System. ICHOR is designed to treat organized thrombus and embolic events in the peripheral vasculature. This "one size fits all" system is minimally invasive. - January 24, 2019 - Euphrates Vascular
Pulse Therapeutics and ICHOR Vascular Merge to Form Euphrates Vascular
Company aimed at becoming a leader in the treatment of vascular occlusions. - January 13, 2019 - Euphrates Vascular
GeneFluidics Selected as One of Five Finalists for Antimicrobial Resistance Diagnostic (AMR) Challenge Step 2
GeneFluidics is the only group selected for both NIAID antimicrobial resistance diagnostics projects (https://www.nih.gov/news-events/news-releases/nih-funds-nine-antimicrobial-resistance-diagnostics-projects) and as finalists for the NIH AMR Challenge Step 2 (https://dpcpsi.nih.gov/AMRChallenge/Finalists). - December 05, 2018 - GeneFluidics Inc.
VIRUN® and Algarithm™ to Debut O3Omega™ NOT Peanut Butter and Jelly Sandwich Multi-serving Smoothies in Booth 1637 at Supply Side West Expo, Las Vegas on November 8 and 9
Virun® and Algarithm™ offer chill vibe at otherwise chaotic Supplyside West, serve up adult beverages enhanced with DHA and flavored like deserts, to debut new vegan O3Smoothies flavor, NOT Peanut Butter and Jelly. - November 02, 2018 - VIRUN
AdvantaPure(R) Introduces AdvantaSil(TM) Ultra Low Temperature Silicone Tubing That’s Engineered for Temperatures as Low as -112°C
New AdvantaSil Ultra Low Temperature Silicone Tubing is designed to aid pharmaceutical and biopharm manufacturers with protecting their high-value cell and drug products. The platinum-cured tubing is engineered for Single-Use applications involving cold storage and transport. It’s the first commercially-available tubing engineered for flexibility and crush resistance upon removal from a minus 86 degrees C freezer. A video on AdvantaPure’s website shows the test procedures and results. - November 01, 2018 - AdvantaPure
ALPCO Launches FDA Class I Exempt STELLUX® Glucagon ELISA
ALPCO announces launch of its new highly specific FDA Class I Exempt STELLUX® Chemi Glucagon ELISA. - October 23, 2018 - ALPCO
ALPCO Announces Inaugural Young Investigators Award Recipient
ALPCO announces the first recipient of its new young investigators award, the Diabetes Research Travel Grant. - October 17, 2018 - ALPCO
Tornado Spectral Systems Wins 2018 CPhI Pharma Award
Tornado Spectral Systems was recognized as the winner of the "Analysis, Testing, and Quality Control" award at the prestigious CPhI Pharma Awards (2018) in Madrid, Spain. The CPhI Pharma Awards are among the most coveted recognitions in the pharma industry, celebrating innovations breaking new ground and supporting companies committed to industry excellence. - October 17, 2018 - Tornado Spectral Systems